Clinical Trial Update: Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigated atorvastatin as a treatment adjunct for pulmonary tuberculosis in Nigeria, spanning Phase 2 and Phase 3 and now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis
• Tuberculosis Pulmonary

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Obafemi Awolowo University Teaching Hospital | Conditions: Tuberculosis, Pulmonary, Tuberculosis | Phase 2, Phase 3 | Status: COMPLETED